Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial

Abstract Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD‐PH) using phosphodiesterase type‐5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, patients with COPD‐PH from five Department of Veterans Aff...

Full description

Bibliographic Details
Main Authors: Bradley A. Maron, Gaurav Choudhary, Rebekah L. Goldstein, Eric Garshick, Matthew Jankowich, Troo J. S. Tucker, Kathleen A. LaCerda, Brack Hattler, Edward C. Dempsey, Ruxana T. Sadikot, Shelley Shapiro, Sharon I. Rounds, Ronald H. Goldstein
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Pulmonary Circulation
Subjects:
exercise capacity
lung disease
pulmonary vascular disease
Online Access:https://doi.org/10.1002/pul2.12043

Internet

https://doi.org/10.1002/pul2.12043

Similar Items